RxSave Card Raises $1.7M Pre‑Seed to Revolutionize Prescription Drug Savings for Employers
RxSave Card, a Chicago‑based healthcare technology startup focused on reducing prescription drug costs for employers and employees, has successfully raised $1.7 million in pre‑seed funding to build and scale its innovative pharmacy benefit platform that delivers transparent pricing and immediate savings at the point of sale. The funding marks a significant early milestone for the company as it seeks to challenge traditional pharmacy benefit management models and expand access to lower prescription costs nationwide.
The pre‑seed round was led by Distributed Ventures, an early‑stage venture fund that specializes in insurtech, employer solutions and fintech investments, with participation from industry insiders who bring deep expertise in employee benefits and pharmacy cost strategies. This infusion of capital positions RxSave Card to accelerate product development, scale its team, and broaden market adoption among employers looking for cost‑effective alternatives to conventional pharmacy benefits.
Founded in 2024 by CEO and co‑founder Chris Crawford, a veteran of the pharmacy benefits space with more than two decades of experience, RxSave Card seeks to simplify how employers and employees access affordable prescription drugs by bypassing complex pharmacy benefit manager (PBM) pricing structures. Crawford has described the company’s mission as empowering employers to fulfill fiduciary obligations to offer lower‑cost prescription options while enhancing transparency and consumer choice at the pharmacy counter.
RxSave Card’s approach centers on enabling employers to preload funds onto a digital card that employees can use at checkout in more than 65,000 participating pharmacies, including online fulfillment services, to automatically capture the lowest available cash or discount card price. By scanning the card at the pharmacy, the system evaluates available prices in real time and applies the most cost‑effective option, helping employers and employees reduce out‑of‑pocket expenses without requiring changes to existing PBM contracts or benefit plans.
The company’s platform is designed to address several long‑standing challenges in the prescription benefits landscape. Traditional PBM arrangements often limit pharmacy choice and obscure pricing through rebates and administrative fees, which can result in higher costs for both plan sponsors and patients. RxSave Card’s model offers an alternative by leveraging transparent pricing strategies and direct savings at the point of sale, which can reduce overall drug spend while complying with fiduciary responsibilities under ERISA for self‑insured employers.
The new funding will specifically enable RxSave Card to accelerate the development of its technology and enhance the user experience for employers and participating pharmacies. The capital will support investments in engineering and operations, expansion of the company’s pharmacy network, and outreach to employer groups and benefits consultants who can integrate the solution into existing benefits programs.
Distributed Ventures, as lead investor, brings strategic insight into the benefits and insurance technology ecosystem, reflecting confidence in RxSave Card’s ability to address cost pressures in the more than $600 billion American prescription drug market. Company leadership sees this backing as validation of their approach to reshaping how prescription pricing transparency and savings can be delivered to employers and employees alike.
Industry observers note that the timing for solutions like RxSave Card is favorable, given increasing scrutiny of drug pricing practices, rising prescription costs, and the growing demand from employers for benefit innovations that offer measurable savings without sacrificing access or choice. Recent lawsuits and regulatory focus on PBM practices have further highlighted the need for alternative solutions that can deliver cost savings while maintaining compliance with fiduciary standards.
In addition to its funding and technology development, RxSave Card has formed strategic partnerships with firms in the pharmacy navigation space to integrate its discount pricing network into broader benefits platforms, helping self‑insured employers simplify access to affordable medication options for their members. These collaborations extend the company’s reach and reinforce its value proposition as a complementary tool alongside traditional prescription benefits.
With its pre‑seed capital secured and a clear strategy for growth, RxSave Card is positioned to expand its role in the pharmacy benefits landscape and drive meaningful cost savings for employers and employees. The company’s focus on real‑time pricing transparency and flexible benefit design offers an innovative alternative at a time when many organizations are seeking new ways to manage escalating prescription costs while improving outcomes for their workforce.
